COVID-19 pandemic
Preliminary tests indicate that the Oxford–AstraZeneca COVID-19 vaccine may reduce transmission of COVID-19 and not simply prevent symptomatic infections.
Sources: U.S. News & World Report via MSN
Changes
- Preliminary tests indicate that the Oxford–AstraZeneca COVID-19 vaccine may reduce transmission of COVID-19, and not simply prevent symptomatic infections.
- Preliminary tests indicate that the Oxford–AstraZeneca COVID-19 vaccine may reduce transmission of COVID-19 and not simply prevent symptomatic infections.
Related
Egypt receives its first shipment of 50,000 doses of the AstraZeneca vaccine from India.